Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
نویسنده
چکیده
Methylphenidate, a psychostimulant, is first choice treatment for Attention Deficit Hyperactivity Disorder (ADHD)(Dopfner et al. 2002). Unfortunately, it has many adverse side effects, especially depression and appetite loss, which limits its dosage. There are only a few studies investigating the effect of a combination of Methylphenidate and other psychoactive substances, especially antidepressants (Pataki et al. 1993). Recently, the noradrenaline reuptake inhibitor Atomoxetine has been developed also for this disorder (Purper-Ouakil et al. 2005). Recent literature reports poorer efficacy of Atomoxetine, compared to that of Methlyphenidate (PurperOuakil et al. 2005). Atomoxetine`s antidepressant effect leads to the hypothesis, that it may help to 1. reduce the dosage of Methylphenidate and 2. reduce its above mentioned adverse side effects. For that reason we assume that these problems can be resolved using Atomoxetine additionally to Methylphenidate. We proved this hypothesis on a 11 year old male patient diagnosed as ADHD according to the practice parameters of the American Academy of Child and Adolescence psychiatry, including EEG, blood sample, magnetic resonance tomography, psychological tests (WISC: IQ=97), and Conner Scales, where Methylphenidate (20 mg daily), given for 2 months, led to depressed mood and appetite loss. Reducing its dosage to 10 mg worsened ADHD symptomatology while improving the depressed mood. After 1 month, a switch to Atomoxetine up to 40 mg did not treat the disattention sufficiently. Atomoxetine was given for 2 months. Under additive administration of Methylphenidate (10mg daily) for 3 months, the mood remained stable, while ADHD symptomatology improved impressively. The reported case mainly shows that the combination between atomoxetine and methylphenidate helped reducing the dose of methylphenidate and thus, probably the side effects while showing beneficial clinical effects. Further systematic research should be done to investigate this observation.
منابع مشابه
Atomoxetine Induced Obsessive-Compulsive Disorder
Introduction: Attention deficit and hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children and adolescents. Atomoxetine is a non-stimulant drug used in the treatment of ADHD. Case Presentation: In this article, a case of obsessive-compulsive disorder (OCD) which occurred in an 11-year-old boy with an increased dose of atomoxetin...
متن کاملComparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis
Background: The aim of this study was to directly compare efficacy of atomoxetine and methylphenidate in treatment of children and adolescents 6- 18 years. Methods: All published, randomized, open label or double blind trials, comparing the efficacy of methylphenidate with atomoxetine in treatment of children diagnosed with ADHD, using DSM-IV criteria were included in this study; ADHD...
متن کاملTreatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine
Objective To describe the characteristics and medication treatment patterns of adult patients with attention-deficit/hyperactivity disorder (ADHD) prescribed atomoxetine in Japan. Materials and methods A retrospective analysis of insurance claims data was conducted using the Japan Medical Data Center database. Adults (≥18 years) with ADHD who had ≥1 atomoxetine claim from January 1, 2013 to D...
متن کاملAtomoxetine for the Treatment of ADHD in Incarcerated Adolescents.
Effective interventions for adolescents with attention deficit/hyperactivity disorder (ADHD) in the correctional setting may improve care during incarceration, decrease risk of substance relapse, and reduce recidivism after release from the correctional setting of these individuals. The present report delineates the epidemiology of adolescent ADHD in the correctional setting and its association...
متن کاملAtomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression.
PURPOSE Atomoxetine is a non-stimulant drug that could be an alternative to methylphenidate, whose benefit : risk balance for the treatment of adults with attention deficit hyperactivity disorder (ADHD) has recently been shown to be unclear. This study aimed to compare all-cause discontinuation rate between atomoxetine and placebo in adults with ADHD. Secondarily, efficacy and safety were inves...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Psychiatria Danubina
دوره 21 3 شماره
صفحات -
تاریخ انتشار 2009